상세 보기
한국형 양극성장애 약물치료 알고리듬 2026: 유지치료
- 유빈;
- 박원명;
- 우영섭;
- 정종현;
- 서정석;
- 외 12명
초록
Objectives This paper presents the sixth revision of the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP2026), focusing on maintenance treatment. The update reflects the recent clinical shifts toward atypical antipsychotics (AAP) and safety-centered pharmacological strategies. Methods A consensus-based survey was conducted among 109 Korean experts (67 adult and 42 child/adolescent specialists). Using a nine-point scale, the treatment options were categorized into first-line (7–9), second-line (4–6), and third-line (1–3) strategies. Results For maintenance after a manic episode, first-line recommendations include mood stabilizer (MS) monotherapy, AAP monotherapy, MS+AAP combination, and MS+lamotrigine (LTG). Aripiprazole remains a core agent because of its superior efficacy and safety profile. Following a depressive episode, various combinations, AAP monotherapy, and LTG monotherapy were prioritized. In particular, lurasidone, added to the KMAP-BP questionnaire for the first time, was recommended as a first-line agent in patients with bipolar disorder type II (BD-II) depressive symptoms. For BD-II maintenance treatment, LTG, lurasidone, and aripiprazole received the highest preference scores to address frequent depressive relapses. In mixed features, strong consensus on continuing MS and AAP was reached while recommending early discontinuation of antidepressants (within 4 months). Expert consensus shifted significantly toward “long-term maintenance as possible” for AAPs to prevent recurrence and promote functional recovery. Conclusion KMAP-BP2026 highlights a paradigm shift toward an AAP-centered maintenance framework, stringent restrictions on antidepressant use, and the clinical integration of newer agents like lurasidone. These guidelines provide a practical, evidence-based framework for clinicians to establish individualized, long-term treatment plans aimed at minimizing relapses and enhancing the quality of life for patients.
키워드
- 제목
- 한국형 양극성장애 약물치료 알고리듬 2026: 유지치료
- 제목 (타언어)
- Korean Medication Algorithm Project for Bipolar Disorder 2026: Maintenance Therapy
- 저자
- 유빈; 박원명; 우영섭; 정종현; 서정석; 양찬모; 윤성훈; 전덕인; 박성용; 김원; 김낙영; 최원석; 이문수; 양현주; 정영은; 김문두; 윤보현
- 발행일
- 2026-08
- 유형
- Y
- 권
- 65
- 호
- 3
- 페이지
- 200 ~ 299
- 언어
- KOR
- 출판사
- 대한신경정신의학회
- 발행국가
- 대한민국
- 분량
- 100 페이지
- ISSN
- E 2289-0963
P 1015-4817